Dengue incidence in urban and rural cambodia: Results from population-based active fever surveillance, 2006-2008

PLoS Neglected Tropical Diseases

Volumn 4, Issue 11, 2010, Pages

  Vong, Sirenda ^a   Khieu, Virak ^a   Glass, Olivier ^a   Ly, Sowath ^a   Duong, Veasna ^a   Huy, Rekol ^b   Ngan, Chantha ^b   Wichmann, Ole ^c   William Letson, G ^c   Margolis, Harold S ^c   Buchy, Philippe ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b Ministry of Health Cambodia   (Cambodia)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CAMBODIA; CHILD; CONTROLLED STUDY; DENGUE; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FEVER; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; URBAN RURAL DIFFERENCE; BLOOD; DENGUE VIRUS; GENETICS; HEALTH; HEALTH SURVEY; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CAMBODIA; CHILD; DENGUE; DENGUE VIRUS; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; POPULATION SURVEILLANCE; RURAL HEALTH; URBAN HEALTH; YOUNG ADULT;

EID: 78649790025     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000903     Document Type: Article

References (49)

1. Gubler DJ, Clark GG (1995) Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1: 55-57.
2. Guzman MG, Kouri G (2003) Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27: 1-13.
3. Ooi EE, Goh KT, Gubler DJ (2006) Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis 12: 887-893.
4. Guzman MG, Kouri G (2002) Dengue: An update. Lancet Infect Dis 2: 33-42.
5. Lang J (2009) Recent progress on sanofi pasteur's dengue vaccine candidate. J Clin Virol 46(Suppl 2): S20-S24.
6. Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, et al. (2010) A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J Infect Dis 201(3): 370-377.
7. DeRoeck D, Deen J, Clemens JD (2003) Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four Southeast Asian countries. Vaccine 22: 121-129.
8. Mahoney RT, Krattiger A, Clemens JD, Curtiss R, 3rd (2007) The introduction of new vaccines into developing countries. IV: Global Access Strategies. Vaccine 25: 4003-4011.
9. Huy R, Buchy P, Conan A, Ngan C, Ong S, et al. (2010) National dengue surveillance in Cambodia, 1980 - 2008: Insights on epidemiological and virological trends and impact of vector control interventions. Bull World Health Organ 88: 650-657.
10. Huy R, Wichmann O, Beatty M, Ngan C, Duong S, et al. (2009) Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Pub Health 9: 155.
11. Chhour YM, Ruble G, Hong R, Minn K, Kdan Y, et al. (2002) Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 8: 485-489.
12. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, et al. (2007) Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 369: 1452-1459.
13. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
14. Burke DS, Nisalak A, Johnson DE, Scott RM (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38(1): 172-180.
15. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, et al. (1999) A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 61(3): 412-419.
16. Chareonsook O, Foy HM, Teeraratkul A, Silarug N (1999) Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect 122: 161-166.
17. Kumar A, Sharma SK, Padbidri VS, Thakare JP, Jain DC, et al. (2001) An outbreak of dengue fever in rural areas of northern India. J Commun Dis 33: 274-281.
18. Strickman D, Sithiprasasna R, Kittayapong P, Innis BL (2000) Distribution of dengue and Japanese encephalitis among children in rural and suburban Thai villages. Am J Trop Med Hyg 63(1-2): 27-35.
19. Rossi CA, Ksiazek TG (1998) Enzyme-linked immunosorbent assay (ELISA). In Lee HW, Calisher C, Schmaljohn C, eds. Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Seoul: WHO Collaborating Center for Virus Reference and Research. pp 87-91.
20. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, et al. (2009) Evaluation of commercially available anti-dengue virus Immunoglubulin M tests. Emerg Infect Dis 15: 436-440.
21. Buchy P, Vo VL, Bui KT, Trinh TX, Glaziou P, et al. (2005) Secondary dengue virus type 4 infections in Vietnam. Southeast Asian J Trop Med Public Health 36(1): 178-185.
22. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30(3): 545-551.
23. Reynes JM, Ong S, Mey C, Ngan C, Hoyer S, Sall AA (2003) Improved molecular detection of dengue virus serotype 1 variants. J Clin Microbiol 41: 3864-3867.
24. Gubler DJ (1986) Application of serotype-specific monoclonal antibodies for identification of dengue viruses. In: Yunker C, ed. Arboviruses and arthropod cells in vitro. Boca Raton: CRC Press. pp 3-14.
25. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156(1): 40-51.
26. Yoksan S, Tubthong K, Kanitwithayanun W, Jirakanjanakit N (2009) Laboratory assays and field dengue vaccine evaluation at Ratchaburi province, Thailand: a preliminary result. J Clin Virol 46(Suppl 2): S13-S15.
27. Tien NT, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VT, et al. (2010) Prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 104(9): 592-600.
28. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. (2005) Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg 72(1): 60-66.
29. Morrison AC, Minnick SL, Rocha C, Forshey BM, Stoddard ST, et al. (2010) Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis 4(5): e670.
30. Kuan G, Gordon A, Avile ́s W, Ortega O, Hammond SN, et al. (2009) The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases. Am J Epidemiol 170(1): 120-129.
31. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, et al. (2010) Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201(1): 5-14.
32. Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, et al. (1998) Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 4(1): 89-92.
33. Peláez O, Guzmán MG, Kourí G, Pérez R, San Marti ́n JL, et al. (2004) Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis 10(4): 719-22.
34. Rocha C, Morrison AC, Forshey BM, Blair PJ, Olson JG, et al. (2009) Comparison of two active surveillance programs for the detection of clinical dengue cases in Iquitos, Peru. Am J Trop Med Hyg 80(4): 656-660.
35. National Institute of Public Health, National Institute of Statistics [Cambodia] and ORC Macro (2006) Cambodia demographic and health survey 2005. Available: http://cambodia.unfpa.org/docs/CDHS_Preliminary_Report_2005.pdf.
36. Chanama S, Anantapreecha S, A-nuegoonpipat A, Sa-gnasang A, Kurane I, et al. (2004) Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J Clin Virol 31: 185-189.
37. Kay B, Nam VS (2005) New strategy against Aedes aegypti in Vietnam. Lancet 365: 613-617.
38. Socheat D, Chanta N, Setha T, Hoyer S, Chang MS, et al. (2004) The development and testing of water storage jar covers in Cambodia. Dengue Bull 28: 6-12. Available: http://www.searo.who.int/LinkFiles/Dengue_Bulletin_Volume_28_Dengue_Bulletin_Vol-28_2004_(supplement).pdf.
39. Mammen MP, Pimgate C, Koenraadt CJ, Rothman AL, Aldstadt J, et al. (2008) Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med 5: e205.
40. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
41. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, et al. (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4(3): e617.
42. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, et al. (2007) Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg 77: 910-913.
43. Carlos CC, Oishi K, Cinco MT, Mapua CA, Inoue S, et al. (2005) Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg 73: 435-440.
44. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, et al. (2003) Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
45. Scott TW, Morrison AC (2003) Aedes aegypti density and the risk of dengue virus transmission. IN Takken W, Scott TW, eds. Ecological aspects for application of genetically modified mosquitoes. Dordrecht, The Nederlands: FRONTIS. Pp 187-206.
46. Kuno G (1995) Review of the factors modulating dengue transmission. Epidemiol Rev 17: 321-335.
47. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230: 244-251.
48. Adams B, Holmes EC, Zhang C, Mammen MP, Jr., Nimmannitya S, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA 103: 14234-14239.
49. Hombach J (2009) Guidelines for clinical trials of dengue vaccine in endemic areas. J Clin Virol 46(Suppl 2): S7-S9.